Related content

Response to Chiasson et al.: Acarbose for the prevention of Type 2 diabetes, hypertension and cardiovascular disease in subjects with impaired glucose tolerance: facts and interpretations concerning the critical analysis of the STOP-NIDDM Trial data

By Sawicki P.   Kaiser T.  

Diabetologia, Vol. 47, Iss. 6, 2004-06 ,pp. : 976-977

Springer Publishing Company

Access to resources Recommend Favorite

Acarbose for the prevention of Type 2 diabetes, hypertension and cardiovascular disease in subjects with impaired glucose tolerance: facts and interpretations concerning the critical analysis of the STOP-NIDDM Trial data

By Chiasson J.-L.   Josse R.   Gomis R.   Hanefeld M.   Karasik A.   Laakso M.  

Diabetologia, Vol. 47, Iss. 6, 2004-06 ,pp. : 969-975

Springer Publishing Company

Access to resources Recommend Favorite

Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2

By Ekbom Tord   Linjer Erland   Hedner Thomas   Lanke Jan   de Faire Ulf   Wester P.-O.   Dahlöf Björn   Scherstén Bengt  

Blood Pressure, Vol. 13, Iss. 3, 2004-06 ,pp. : 137-141

Informa Healthcare

Access to resources Recommend Favorite

Hypertension and Diabetes: Critical Comorbidities

By Bongiovanni Cheryl M.  

Journal for Vascular Ultrasound, Vol. 32, Iss. 1, 2008-03 ,pp. : 17-20

Society for Vascular Ultrasound

Access to resources Recommend Favorite

Prevention of cardiovascular disease in uncomplicated, mild hypertension – need for prospective data from intervention trials

By Kjeldsen Sverre   Hedner Thomas   Himmelmann Anders  

Blood Pressure, Vol. 13, Iss. 1, 2004-02 ,pp. : 5-6

Informa Healthcare

Access to resources Recommend Favorite